Particle.news

Download on the App Store

Multidose Home Ondansetron Reduces Pediatric Vomiting Recurrence and Earns Guideline Endorsement

Investigators have begun subgroup analyses to tailor prescribing to children most likely to benefit

Image

Overview

  • A national double-blind randomized trial across six Canadian pediatric hospitals enrolled over 1,000 children aged six months to 18 years to assess home ondansetron use after ED discharge.
  • Children who received a small multidose supply at home experienced significantly lower rates of moderate-to-severe vomiting recurrence.
  • The New England Journal of Medicine published the study on July 16, and TREKK has incorporated the findings into its national emergency discharge guidelines.
  • Pediatric Emergency Research Canada network co-founders highlighted the trial as a model for cross-country collaboration in pediatric emergency medicine.
  • Acute gastroenteritis drives more than two million pediatric ED visits and over 50,000 hospitalizations annually in North America, emphasizing the impact of improved outpatient care.